08/11/2024  17:25:45 Diferencia -1.055 Volumen Bid18:51:45 Ask18:51:45 Capitalización de mecado Dividendo A. P/E Ratio
31.775EUR -3.21% 0
Volumen de negocios: 0.000
31.610Volumen de oferta: 950 32.270Tamaño/ Volumen/ Formato de Ask: 930 16.13 mil millonesEUR - -

Descripción de negocio

Baxter and the Baxter International Foundation are committed to saving and sustaining lives and creating healthier communities. The company focuses on three core areas including improving access to healthcare; fostering tomorrow’s innovation and serving its communities. Baxter works closely with public and private partners around the world to ensure people have access to the healthcare they need, to develop the next generation of innovators who will lead the way in advancing care, and to create long-lasting impact in Baxter’s communities. The Baxter International Foundation supports initiatives and organizations that make a positive, lasting impact on increasing access to healthcare for the disadvantaged and underserved.
 

Consejo de gestión & Consejo de supervisión

CEO
Jose (Joe) E. Almeida
Consejo de gestión
James Borzi, Stacey Eisen, Darren Evans, Gerard (Jerry) Greco, Tobi Karchmer, Heather Knight, Talvis Love, Jeanne Mason, Reazur (Reaz) Rasul, David S. Rosenbloom, Alok Sonig, Brian Stevens, Chris Toth, Steve Wallace, Daniel (Dan) Wolf
Consejo de supervisión
Jose (Joe) E. Almeida, William A. Ampofo II, Michael F. Mahoney, Patricia B. Morrison, Ste hen N. Oesterle, Stephen H. Rusckowski, Nancy M. Schlichting, Brent Shafer, Cath R. Smith, Amy A. Wendell, David S. Wilkes, Peter M. Wilver
 

Datos de la empresa

Nombre: Baxter International Inc.
Dirección: One Baxter Parkway,Deerfield, IL 60015, USA
Teléfono: +1-224-948-2000
Fax: -
E-mail: -
Internet: www.baxter.com
Industria: Healthcare
Sector: Medical Products
Subsector: Advanced Medical Devices
Fin del año financiero: 31/12
Acciones de libre circulación: 73.60%
Fecha de OPI: 13/01/1978

Relación con inversores

Nombre: Clare Trachtman
IR teléfono: +1-224-948-3020
IR-fax: +1-224-948-4498
IR e-mail: Global_CORP_Investor...ter.com Global_CORP_Investor_Relations@baxter.com

Calendario de la empresa

CW 45 | 08/11/2024 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

Otros
 
50.39%
Vanguard Group
 
11.80%
BlackRock Inc.
 
11.71%
Dodge & Cox
 
5.37%
PZENA INVESTMENT MANAGEMENT LLC
 
4.76%
State Street Corporation
 
4.19%
PRICE T ROWE ASSOCIATES INC MD
 
3.21%
JP Morgan Chase & Co.
 
2.41%
Ameriprise Financial Inc.
 
2.18%
Otros
 
3.98%